Skip to main content
. 2013 May;68(5):612–620. doi: 10.6061/clinics/2013(05)06

Table 1.

Selected descriptive characteristics among 306 participants (199 men and 107 women), Belo Horizonte (MG), 2001-2002.

Characteristics Total Men Women
na (%) na (%) na (%)
SOCIODEMOGRAPHICS
Age (years)
    >33 148 (48.4) 99 (49.8) 49 (45.8)
    ≤33 158 (51.6) 100 (50.2) 58 (54.2)
Race
Non-white 218 (74.4) 137 (72.5) 81 (77.9)
    White 75 (25.6) 52 (27.5) 23 (22.1)
Schooling (years)
    ≤4 83 (27.2) 39 (19.7) 44 (41.1)
    4-8 85 (27.9) 61 (30.8) 24 (22.4)
    ≥8 137 (44.9) 98 (49.5) 39 (36.5)
Marital status
    Single/Divorced/Widowed 198 (64.7) 135 (67.8) 63 (58.9)
    Married/Stable union 108 (35.3) 64 (32.2) 44 (41.1)
Individual income in last month
    Yes 179 (58.9) 123 (62.1) 56 (52.8)
    No 125 (41.1) 75 (37.9) 50 (47.2)
Job schedule
    Unfixed 59 (19.3) 46 (23.1) 13 (12.1)
    Fixed 137 (44.8) 100 (50.3) 37 (34.6)
    Unemployed 110 (36.0) 53 (26.6) 57 (53.3)
BEHAVIOR
Disclosure of HIV status
    Yes 255 (86.4) 167 (85.6) 88 (88.0)
    No 40 (13.6) 28 (14.4) 12 (12.0)
Alcohol use in month prior to baseline interview
    Yes 111 (37.6) 78 (40.0) 33 (33.0)
    No 184 (62.4) 117 (60.0) 67 (67.0)
Current tobacco use
    Yes 101 (34.2) 75 (38.5) 26 (26.0)
    No 194 (65.8) 120 (61.5) 74 (74.0)
Lifetime injection drug use
    Yes 17 (5.8) 15 (7.7) 2 (2.0)
    No 278 (94.2) 180 (92.3) 98 (98.0)
Lifetime illicit drug use
    Yes 83 (28.1) 74 (38.0) 9 (9.0)
    No 212 (71.9) 121 (62.0) 91 (91.0)
HEALTH SERVICES
Recruitment site
    CTR/DIP 248 (81.1) 158 (79.4) 90 (84.1)
    HEM 58 (18.9) 41 (20.6) 17 (15.9)
Difficulty in searching for HIV service
    Yes 27 (9.2) 20 (10.3) 7 (7.1)
    No 266 (90.8) 174 (89.7) 92 (92.9)
Number of attended HIV health service
    Only one 227 (77.0) 151 (77.4) 76 (76.0)
    More than one 68 (23.0) 44 (22.6) 24 (24.0)
Psychological support
    Yes 16 (5.4) 10 (5.1) 6 (6.1)
    No 278 (94.6) 85 (94.9) 93 (93.9)
Understanding of medical counseling
    Sufficient 212 (69.7) 143 (72.2) 69 (65.1)
    Insufficient 76 (25.0) 44 (22.2) 32 (30.2)
    Did not receive 16 (5.3) 11 (5.6) 5 (4.7)
Understanding of pharmaceutical counseling
    Sufficient 247 (80.7) 160 (80.4) 87 (81.3)
    Insufficient 33 (10.8) 23 (11.6) 10 (9.4)
    Did not receive 26 (8.5) 16 (8.0) 10 (9.4)
Understanding of ART prescription
    Sufficient 152 (49.7) 99 (49.8) 53 (49.5)
    Insufficient 154 (50.3) 100 (50.2) 54 (50.5)
CLINICAL
Number of prescribed pills/day
    <7 134 (43.8) 85 (42.7) 49 (45.8)
7-12 122 (39.9) 85 (42.7) 37 (34.6)
>12 50 (16.3) 29 (14.6) 21 (19.6)
Self-reported difficulty of antiretroviral treatment
    Low 141 (47.8) 94 (48.2) 47 (47.0)
    High 154 (52.2) 101 (51.8) 53 (53.0)
Clinical classification
    Symptomatic (B-C) 168 (56.8) 110 (57.3) 58 (55.8)
    Asymptomatic (A) 128 (43.2) 82 (42.7) 46 (44.2)
Baseline TCD4+ lymphocyte count
    <200/mm3 160 (58.8) 103 (59.5) 57 (57.6)
    ≥200/mm3 112 (41.2) 70 (40.5) 42 (42.4)
Number of adverse reactions reported
    <3 84 (27.5) 58 (29.3) 26 (24.3)
    ≥3 221 (72.5) 140 (70.7) 81 (75.7)
Time between HIV test and first ART prescription
    <113 days 152 (49.7) 111 (55.8) 41 (38.3)
    ≥113 days 154 (50.3) 88 (44.2) 66 (61.7)
Time between first medical visit and first ART prescription
    <43 days 144 (47.1) 103 (51.8) 41 (38.3)
    ≥43 days 162 (52.9) 96 (48.2) 66 (61.7)
Self-perceived quality of life
    Good 170 (58.2) 121 (62.7) 49 (49.5)
    Poor 122 (41.8) 72 (37.3) 50 (50.5)
Baseline anxiety symptoms
    None-mild 189 (64.5) 136 (70.5) 53 (53.0)
    Moderate-severe 104 (35.5) 57 (29.5) 47 (47.0)
Baseline depression symptoms
    None-mild 229 (78.2) 163 (84.5) 66 (66.0)
    Moderate-severe 64 (21.8) 30 (15.5) 34 (34.0)

a Total for each variable differs as a result of missing values.